Pictet Asset Management
CBAY

Pictet Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Pictet Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,197
Closed -$288K – 2036
2023
Q4 		$288K Hold
12,197
– – ﹤0.01% 1566
2023
Q3 		$182K Buy
+12,197
New +$162K ﹤0.01% 1714

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pictet Asset Management's CBAY Position: Q1 2024 in Review

Pictet Asset Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 12,197 shares — an estimated $288K sold.

Pictet Asset Management first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $288K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Pictet Asset Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Pictet Asset Management sold 12,197 Cymabay Therapeutics shares in Q1 2024, an estimated $288K.
  • Pictet Asset Management first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Pictet Asset Management's Cymabay Therapeutics position peaked at $288K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Pictet Asset Management's 13F filing for Q1 2024, filed 14 May 2024.